Declaración lamentable contra los franceses

A 111/003(03

Ventilación de alta frecuencia, una opción terapéutica

The oscillatory high frequency ventilation has emerged as a safe alternative to conventional methods of ventilation in the treatment of neonatal respiratory failure. That is why an observational study was made of retrospective descriptive type with qualitative and quantitative approach to characterize the behavior of high frequency ventilation in neonates treated in Neonatal Service at "Mariana Grajales"  Gynecoobstetric University Hospital in Villa Clara between 2009 and 2014. The exhibition coincided with the universe and it was composed of 68 infants ventilated with high frequency. The information obtained was processed and statistically represented. It was found that the gestational age less than 34 weeks and less than 1500 grams were closely related to the ventilation mode; the failure of conventional mechanical ventilation in the hyaline membrane disease was the most common indication -these patients achieved better gasometrical recovery after used-; infants with less postnatal age had less prolonged stay at high frequency and better oxygenation-ventilation; Recovery was evident when ventilatory stay exceeded 24 hours and survival was achieved in more than half of newborns who used this therapy of ventilation.La ventilación de alta frecuencia oscilatoria ha surgido como una alternativa segura frente a los métodos convencionales de ventilación en el tratamiento de la insuficiencia respiratoria neonatal. Es por ello que se realizó un estudio  de tipo descriptivo retrospectivo con el objetivo de caracterizar el comportamiento de la ventilación de alta frecuencia en los recién nacidos atendidos en el Servicio de Neonatología del Hospital Universitario Ginecoobstétrico “Mariana Grajales” de Villa Clara entre los años 2009 y 2014. La muestra coincidió con el universo y estuvo compuesta por 68 recién nacidos ventilados con alta frecuencia. La información obtenida fue procesada y representada estadísticamente. Se obtuvo que la edad gestacional menor de 34 semanas y el peso inferior a 1 500 gramos se relacionaron estrechamente con esta modalidad ventilatoria; el fracaso de la ventilación mecánica convencional en la enfermedad de la membrana hialina fue la indicación más frecuente -estos pacientes lograron mejor recuperación gasométrica después de empleada-; los neonatos con menor edad posnatal tuvieron una estadía menos prolongada en alta frecuencia y mejores resultados de la oxigenación-ventilación; se evidenció la recuperación cuando la estadía ventilatoria superó las 24 horas y se logró sobrevida en más de la mitad de los recién nacidos que utilizaron esta ventiloterapia

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Carta pastoral que con motivo de la sacrilegia muerte dada a Luis XVI Rey de Francia

Precede ó tít.: "cruz latina"Sign.: A-E, F<1

Carta pastoral que con motivo de la sacrilega muerte dada a Luis XVI, rey de Francia escribió el obispo de la Rochela al Clero y Fieles ...

Precede al tít.: [Christus]Precede ó tít.: [Christus]Sign.: A-E\p4\s, F\p1\

[Carta] 1620 jun. 12, Nápoles, a S. M. [Manuscrito]

Carta en la que le dice a S.M. haber estado pronto con sus hijos para acudir a su real servicio en los reinos de Nápoles1 bifoli

Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of Europe (RoE) and the World (RoW). Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a subset of the 909 participating centres from 108 countries, were analyzed. Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a significantly lower decrease (p &lt; 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p = 0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere else in the West. Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p &lt; 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection